“…Likewise, two recent cross-sectional studies on newly diagnosed AML patients receiving IC and one longitudinal study of AML patients undergoing prolonged chemotherapy documented a high prevalence of traumatic stress symptoms, intense worrying and sadness, uncertainty about durable remission, and fear of cancer recurrence as serious threat to psychological well-being [4,5,8]. Correspondingly, several qualitative studies investigating patients' perspectives on the initial phase of leukemia diagnosis, IC, and bone marrow transplantation (BMT) noted a sense of shock, emotional numbness, threat, insecurity, uncertainty, and fear regarding diagnosis, invasive procedures, cancer recurrence, and transplant rejection [9][10][11][12]. Although data from the initial phase of leukemia diagnosis and treatment may provide some guidance, additional research is needed to explore longer-term physical and psychosocial implications of leukemia and inform effective care plans to enhance quality of life in leukemia survivorship.…”